These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 20221573)

  • 1. [Cutaneous mesenchymal stem cells. Current status of research and potential clinical applications].
    Sellheyer K; Krahl D
    Hautarzt; 2010 May; 61(5):429-34. PubMed ID: 20221573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin mesenchymal stem cells: prospects for clinical dermatology.
    Sellheyer K; Krahl D
    J Am Acad Dermatol; 2010 Nov; 63(5):859-65. PubMed ID: 20471137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cell therapy in skin: why and what for?
    Khosrotehrani K
    Exp Dermatol; 2013 May; 22(5):307-10. PubMed ID: 23614735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdifferentiated mesenchymal stem cells as alternative therapy in supporting nerve regeneration and myelination.
    Keilhoff G; Stang F; Goihl A; Wolf G; Fansa H
    Cell Mol Neurobiol; 2006; 26(7-8):1235-52. PubMed ID: 16779672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cells: characteristics and clinical applications.
    Bobis S; Jarocha D; Majka M
    Folia Histochem Cytobiol; 2006; 44(4):215-30. PubMed ID: 17219716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo characterization of neurally modified mesenchymal stem cells induced by epigenetic modifiers and neural stem cell environment.
    Alexanian AR; Maiman DJ; Kurpad SN; Gennarelli TA
    Stem Cells Dev; 2008 Dec; 17(6):1123-30. PubMed ID: 18484898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cells as immunomodulator therapies for immune-mediated systemic dermatoses.
    Reddy BY; Xu DS; Hantash BM
    Stem Cells Dev; 2012 Feb; 21(3):352-62. PubMed ID: 21864110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction system of neural and muscle lineage cells from bone marrow stromal cells; a new strategy for tissue reconstruction in degenerative diseases.
    Kitada M; Dezawa M
    Histol Histopathol; 2009 May; 24(5):631-42. PubMed ID: 19283670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of mesenchymal stem cells as treatment for graft-versus-host disease: current knowledge and controversies.
    Ortín M; Sierra J
    Immunotherapy; 2011 Jun; 3(6):701-4. PubMed ID: 21668303
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of mesenchymal (skeletal) stem cells for treatment of degenerative diseases: current status and future perspectives.
    Abdallah BM; Kassem M
    J Cell Physiol; 2009 Jan; 218(1):9-12. PubMed ID: 18726996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Implications of Newly Identified Stem Cell Populations From the Skin Dermis.
    Chen Z; Wang Y; Shi C
    Cell Transplant; 2015; 24(8):1405-22. PubMed ID: 24972091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mesenchymal stem cells and immunomodulation: toward new immunosuppressive strategies for the treatment of autoimmune diseases?].
    Larghero J; Vija L; Lecourt S; Michel L; Verrecchia F; Farge D
    Rev Med Interne; 2009 Mar; 30(3):287-99. PubMed ID: 18930338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Insights into the Neural Differentiation Potential of Canine Adipose Tissue-Derived Mesenchymal Stem Cells.
    Blecker D; Elashry MI; Heimann M; Wenisch S; Arnhold S
    Anat Histol Embryol; 2017 Jun; 46(3):304-315. PubMed ID: 28401575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and neurological assessments after autologous transplantation of bone marrow mesenchymal stem cells in subjects with chronic spinal cord injury.
    Mendonça MV; Larocca TF; de Freitas Souza BS; Villarreal CF; Silva LF; Matos AC; Novaes MA; Bahia CM; de Oliveira Melo Martinez AC; Kaneto CM; Furtado SB; Sampaio GP; Soares MB; dos Santos RR
    Stem Cell Res Ther; 2014 Nov; 5(6):126. PubMed ID: 25406723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential mesenchymal stem cell therapy for skin diseases.
    Li X; Hamada T; Ohata C; Furumura M; Hashimoto T
    Exp Dermatol; 2013 Aug; 22(8):515-6. PubMed ID: 23879810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on mesenchymal stem cell-based therapy in lupus and scleroderma.
    Cras A; Farge D; Carmoi T; Lataillade JJ; Wang DD; Sun L
    Arthritis Res Ther; 2015 Nov; 17():301. PubMed ID: 26525582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunosuppressive properties of non-cultured dermal-derived mesenchymal stromal cells and the control of graft-versus-host disease.
    Gao L; Liu F; Tan L; Liu T; Chen Z; Shi C
    Biomaterials; 2014 Apr; 35(11):3582-8. PubMed ID: 24468404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound-Assisted Liposuction Does Not Compromise the Regenerative Potential of Adipose-Derived Stem Cells.
    Duscher D; Atashroo D; Maan ZN; Luan A; Brett EA; Barrera J; Khong SM; Zielins ER; Whittam AJ; Hu MS; Walmsley GG; Pollhammer MS; Schmidt M; Schilling AF; Machens HG; Huemer GM; Wan DC; Longaker MT; Gurtner GC
    Stem Cells Transl Med; 2016 Feb; 5(2):248-57. PubMed ID: 26702129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of activated Schwann cells with bone mesenchymal stem cells: the best cell strategy for repair after spinal cord injury in rats.
    Ban DX; Ning GZ; Feng SQ; Wang Y; Zhou XH; Liu Y; Chen JT
    Regen Med; 2011 Nov; 6(6):707-20. PubMed ID: 22050523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplantation of mesenchymal stem cells ameliorates secondary osteoporosis through interleukin-17-impaired functions of recipient bone marrow mesenchymal stem cells in MRL/lpr mice.
    Ma L; Aijima R; Hoshino Y; Yamaza H; Tomoda E; Tanaka Y; Sonoda S; Song G; Zhao W; Nonaka K; Shi S; Yamaza T
    Stem Cell Res Ther; 2015 May; 6(1):104. PubMed ID: 26012584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.